These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30840168)

  • 21. Tumor Oxygenation and Hypoxia Inducible Factor-1 Functional Inhibition via a Reactive Oxygen Species Responsive Nanoplatform for Enhancing Radiation Therapy and Abscopal Effects.
    Meng L; Cheng Y; Tong X; Gan S; Ding Y; Zhang Y; Wang C; Xu L; Zhu Y; Wu J; Hu Y; Yuan A
    ACS Nano; 2018 Aug; 12(8):8308-8322. PubMed ID: 30102510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor hypoxia: a new PET imaging biomarker in clinical oncology.
    Tamaki N; Hirata K
    Int J Clin Oncol; 2016 Aug; 21(4):619-625. PubMed ID: 26577447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles.
    Peeters SG; Zegers CM; Yaromina A; Van Elmpt W; Dubois L; Lambin P
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):39-57. PubMed ID: 25517080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors.
    Sobhanifar S; Aquino-Parsons C; Stanbridge EJ; Olive P
    Cancer Res; 2005 Aug; 65(16):7259-66. PubMed ID: 16103077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiolabelled agents for PET imaging of tumor hypoxia.
    Kurihara H; Honda N; Kono Y; Arai Y
    Curr Med Chem; 2012; 19(20):3282-9. PubMed ID: 22664246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined MR Imaging of Oxygen Consumption and Supply Reveals Tumor Hypoxia and Aggressiveness in Prostate Cancer Patients.
    Hompland T; Hole KH; Ragnum HB; Aarnes EK; Vlatkovic L; Lie AK; Patzke S; Brennhovd B; Seierstad T; Lyng H
    Cancer Res; 2018 Aug; 78(16):4774-4785. PubMed ID: 29945958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics.
    Airley RE; Mobasheri A
    Chemotherapy; 2007; 53(4):233-56. PubMed ID: 17595539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Imaging of Tumor Hypoxia: Existing Problems and Their Potential Model-Based Solutions.
    Shi K; Ziegler SI; Vaupel P
    Adv Exp Med Biol; 2016; 923():87-93. PubMed ID: 27526129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Tumor Hypoxia in C6 Glioma Rat Model With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Hou W; Xue Y; Tang W; Pan H; Xu M; Li X; Bi S; Shen Y; Qian Y; Yu Y
    Acad Radiol; 2019 Aug; 26(8):e224-e232. PubMed ID: 30385206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia-inducible factor 1-mediated characteristic features of cancer cells for tumor radioresistance.
    Harada H
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i99-i105. PubMed ID: 26983985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor oxygen measurements and personalized medicine.
    Okunieff P; O'Dell W; Zhang M; Zhang L; Maguire D
    Adv Exp Med Biol; 2013; 765():195-201. PubMed ID: 22879033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a mathematical model to estimate intra-tumor oxygen concentrations through multi-parametric imaging.
    Lee CW; Stantz KM
    Biomed Eng Online; 2016 Oct; 15(1):114. PubMed ID: 27733170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prospect of hypoxia imaging of nuclear medicine in tumors].
    Chen G; Wang RF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):335-inside back cover. PubMed ID: 16778985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft.
    Bharti SK; Mironchik Y; Wildes F; Penet MF; Goggins E; Krishnamachary B; Bhujwalla ZM
    Oncotarget; 2018 Mar; 9(20):15326-15339. PubMed ID: 29632647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to Modulate Tumor Hypoxia for Preclinical In Vivo Imaging Research.
    De Bruycker S; Vangestel C; Staelens S; Van den Wyngaert T; Stroobants S
    Contrast Media Mol Imaging; 2018; 2018():4608186. PubMed ID: 30420794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting hypoxia in tumor: a new promising therapeutic strategy.
    Bosco MC; D'Orazi G; Del Bufalo D
    J Exp Clin Cancer Res; 2020 Jan; 39(1):8. PubMed ID: 31924239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of hypoxia in the hallmarks of human cancer.
    Ruan K; Song G; Ouyang G
    J Cell Biochem; 2009 Aug; 107(6):1053-62. PubMed ID: 19479945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor acidity-activatable manganese phosphate nanoplatform for amplification of photodynamic cancer therapy and magnetic resonance imaging.
    Hao Y; Zheng C; Wang L; Zhang J; Niu X; Song Q; Feng Q; Zhao H; Li L; Zhang H; Zhang Z; Zhang Y
    Acta Biomater; 2017 Oct; 62():293-305. PubMed ID: 28842332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α.
    Schöning JP; Monteiro M; Gu W
    Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):153-161. PubMed ID: 27809360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of hypoxia in tumor angiogenesis-molecular and cellular angiogenic crosstalk.
    Acker T; Plate KH
    Cell Tissue Res; 2003 Oct; 314(1):145-55. PubMed ID: 12898211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.